D011471DisordersC04.588.945.440.770C12.294.260.750C12.294.565.625C12.758.409.75023517080.438658Prostatic Neoplasmsplugins:TwitterTwitterprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:pluginSearchableDataProfilesRNS Plugin Searchable Dataprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonRadiation and Cellular Oncology28.30660.00355048235research area of0.9954560.005310211377subject area forRadiology-Basic SciencesTedSkolarusTed Skolarus41.7886000000000087.598699999999994249Skolarus, TedProfessorhttps://www.uchicagomedicine.org/find-a-physician/physician/stanley-liauwUCMC Stanley Liauw MDoncostanRadiologyUniversity of ChicagoScott E.EggenerScott E. Eggener41.78927490000000-87.601250000000001156Eggener, Scott E.ProfessorStanleyLiauwStanley Liauw41.78927490000000-87.601250000000001228Liauw, StanleyProfessor37639675Ho MD, Yeo KJ, Eggener SEAmerican journal of clinical pathologyTime to stop reporting estimates of any prostate cancer risk with percentage of free prostate-specific antigen. Am J Clin Pathol. 2024 Jan 04; 161(1):1-3.Am J Clin Pathol2024-01-04T00:00:002024Time to stop reporting estimates of any prostate cancer risk with percentage of free prostate-specific antigen.AytekinOto2HZmK7QWEeXakH1rLkPq5g==Aytekin Oto41.78927490000000-87.601250000000002558Oto, AytekinProfessorGregoryKarczmarGregory Karczmar41.78927490000000-87.60125000000000779Karczmar, GregoryProfessor38050021Hernandez KM, Venkat A, Elbers DC, Bihn JR, Brophy MT, Do NV, La J, Liu Q, Prokhorenkov A, Metoki-Shlubsky N, Sung FC, Paller CJ, Fillmore NR, Grossman RLCold Spring Harbor molecular case studiesProstate cancer patient stratification by molecular signatures in the Veterans Precision Oncology Data Commons. Cold Spring Harb Mol Case Stud. 2023 Dec; 9(4).Cold Spring Harb Mol Case Stud2024-01-10T00:00:002024Prostate cancer patient stratification by molecular signatures in the Veterans Precision Oncology Data Commons.38066434Zhuang H, Chatterjee A, Fan X, Qi S, Qian W, He DBMC medical imagingA radiomics based method for prediction of prostate cancer Gleason score using enlarged region of interest. BMC Med Imaging. 2023 12 08; 23(1):205.BMC Med Imaging2023-12-08T00:00:002023A radiomics based method for prediction of prostate cancer Gleason score using enlarged region of interest.38253492Radhakrishnan A, Subramanian L, Rankin AJ, Fetters MD, Wittmann DA, Ginsburg KB, Hawley ST, Skolarus TAAnnals of family medicinePrimary Care Physician and Urologist Perspectives on Optimizing Active Surveillance for Low-Risk Prostate Cancer. Ann Fam Med. 2024 Jan-Feb; 22(1):5-11.Ann Fam Med2024-01-01T00:00:002024Primary Care Physician and Urologist Perspectives on Optimizing Active Surveillance for Low-Risk Prostate Cancer.38438359Patel JN, Jiang C, Owzar K, Hertz DL, Wang J, Mulkey FA, Kelly WK, Halabi S, Furukawa Y, Lassiter C, Dorsey SG, Friedman PN, Small EJ, Carducci MA, Kelley MJ, Nakamura Y, Kubo M, Ratain MJ, Morris MJ, McLeod HLThe pharmacogenomics journalPharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance). Pharmacogenomics J. 2024 Mar 04; 24(2):6.Pharmacogenomics J2024-03-04T00:00:002024Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance).true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessorSurgery-Urology